Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Biller

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Evidence Report/Technology Assessment|December 2, 2009
Treatment of overactive bladder in womenKatherine E Hartmann, Melissa L McPheeters, Danie H Biller, et al.
Journal of Thrombosis and Thrombolysis|April 22, 2008
Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 yearsVijayalakshmi Kunadian, Caitlin Harrigan, Cafer Zorkun, et al.
Journal of Thrombosis and Thrombolysis|September 4, 2008
Transfusion associated microchimerism: a heretofore little-recognized complication following transfusionVijayalakshmi Kunadian, Cafer Zorkun, William J Gibson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2020
A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer SurvivorsLeah H Biller, Chinedu Ukaegbu, Tara G Dhingra, et al.
Journal for Immunotherapy of Cancer|June 21, 2023
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humansVictoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, et al.
Nature Communications|July 18, 2023
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancerAna Babic, Michael H Rosenthal, Tilak K Sundaresan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun, et al.
Journal for Immunotherapy of Cancer|January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term respondersBrandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
JCO Precision Oncology|September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic CancerRishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Evidence Report/Technology Assessment|December 2, 2009
Treatment of overactive bladder in womenKatherine E Hartmann, Melissa L McPheeters, Danie H Biller, et al.
Journal of Thrombosis and Thrombolysis|April 22, 2008
Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 yearsVijayalakshmi Kunadian, Caitlin Harrigan, Cafer Zorkun, et al.
Journal of Thrombosis and Thrombolysis|September 4, 2008
Transfusion associated microchimerism: a heretofore little-recognized complication following transfusionVijayalakshmi Kunadian, Cafer Zorkun, William J Gibson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2020
A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer SurvivorsLeah H Biller, Chinedu Ukaegbu, Tara G Dhingra, et al.
Journal for Immunotherapy of Cancer|June 21, 2023
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humansVictoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, et al.
Nature Communications|July 18, 2023
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancerAna Babic, Michael H Rosenthal, Tilak K Sundaresan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun, et al.
Journal for Immunotherapy of Cancer|January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term respondersBrandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
JCO Precision Oncology|September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic CancerRishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Pageof 8